Stubbs A, et al. - This study focused on the incidence of respiratory infections and progression to bronchiectasis with deteriorating lung function in patients with agammaglobulinemia, taking immunoglobulin replacement therapy. Findings reported that chronic lung disease and progressive impairment of lung function can be seen in many patients despite immunoglobulin replacement therapy.